Skip to content

Comparison of Four Questionnaires for OSA Screening in China

The Comparison of Different Questionnaires for Preoperative Screening and Perioperative Risk Prediction in Obstructive Sleep Apnea Patients in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03074747
Acronym
COQ
Enrollment
1200
Registered
2017-03-09
Start date
2017-03-31
Completion date
2018-12-31
Last updated
2017-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chiari Malformation, Organic Obstructive Sleep Apnea (Diagnosis), Questionnaire

Brief summary

Background: Obstructive sleep apnea (OSA) refers to the apnea and hypopnea caused by upper airway obstruction during sleep. Patients are associated with sleep disorders, frequent desaturation, hypertension, coronary heart disease, cerebrovascular disease and diabetes. OSA prevalence increased in China in recent years. It is estimated that nearly 80% of men and 93% of women are not diagnosed for moderate and severe OSA. Anesthesiologists and surgeons paid more attention on those high risk patients. The gold standard for OSA diagnosis is apnea and hypopnea index (AHI) obtained from polysomnography (PSG). But it is difficult to carry out PSG regularly in primary health care institutions in China for its high cost and long waiting list. So many OSA questionnaires are developed in Europe and North America, obesity is an important risk factor for OSA for them. But in China people have different anatomical characteristics, the diagnosis sensitivity and specificity of those methods has not been reported in China. Methods and Design: Participants for this study will be recruited in Beijing Tongren Hospital scheduled for elective surgery under general anesthesia. A total of 1200 adult male patients will be enrolled. It is including 3 kinds of persons. 1. To accept PSG monitor in sleep center. 2. To receive OSA correction surgery (UPPP). 3. To receive ophthalmological surgery under general anesthesia. Detailed inquiry and record all medical history. Upper airway assessment will be recorded. Preoperative snoring questionnaires will be integrated according to the four questionnaires. All patients complete PSG monitor. For patients undergoing surgical treatment, postoperative continuous pulse oximetry will be recorded for 24 hours. All postoperative adverse events will be recorded. The primary endpoint: All the patients complete the four snoring questionnaires (ASA, Berlin, STOP and STOP-BANG) before PSG test. The secondary endpoints: PSG monitor will be completed before operation. Medical history, upper airway assessment, postoperative 24 hours continuous pulse oximetry monitor and all perioperative adverse events will be recorded. The purpose is to compare the specificity and sensitivity of four questionnaires to figure out OSA. To find suspected OSA patients before operation with one easy-to-use assessment questionnaire and direct OSA clinical practice.

Interventions

DIAGNOSTIC_TESTquestionnaires

After filled the questionnaires, the patients will receive the PSG monitoring

Sponsors

Beijing Tongren Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Adult (18-60ys) 2. Male 3. ASA Ⅰ~Ⅲ grade 4. Applie to receive PSG monitor in sleep center 5. Plan to receive ophthalmological surgery under general anesthesia 6. To accept OSA correction surgery (UPPP)

Exclusion criteria

1. Severe maxillofacial deformities, pharyngeal reconstruction surgery history ( velopharynoplasty, upper and lower jaw orthopedic surgery, cleft lip and palate surgery) 2. Disturbance of consciousness, no self-control ability, serious mental illness, long-term alcohol abuse, drug abuse 3. Took mental or nervous system drugs within 3 months 4. Sleep apnea caused by hypothyroidism, acromegaly, laryngeal spasm, vocal cord paralysis 5. Epilepsy, neuromuscular disease 6. central sleep apnea 7. Ventilator treatment before monitor for more than 1 month 8. Llliteracy 9. Non-Chinese

Design outcomes

Primary

MeasureTime frameDescription
Berlin questionnairFrom randomization to complete PSG monitor, assessed up to 3 monthsThe final reports of the questionnaire
STOP-Bang Scoring ModelFrom randomization to complete PSG monitor, assessed up to 3 monthsThe final reports of the questionnaire
STOP QuestionnaireFrom randomization to complete PSG monitor, assessed up to 3 monthsThe final reports of the questionnaire
ASA ChecklistFrom randomization to complete PSG monitor, assessed up to 3 monthsThe final reports of the questionnaire

Secondary

MeasureTime frameDescription
PSG monitoron the day of PSG reservation or before operationgolden standard for OSA diagnosis

Other

MeasureTime frameDescription
Medical historyFrom randomization to complete PSG monitor, assessed up to 3 monthsto learn about the medical history
continuous pulse oximetry monitorpostoperative 24 hours, continuousTo monitor the saturation after surgery for the first 24 h
adverse eventsduring the induction of anesthesia, the whole period of anesthesia, in PACU and postoperative 24 hoursto record the related adverse events during the perioperative period
upper airway assessmentFrom randomization to complete PSG monitor, assessed up to 3 monthsfor the difficult airway evaluate and management

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026